1-deoxynojirimycin has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambros, JT; Andrés, A; Bernabéu, AÁ; de Dios García Díaz, J; de Juan-Rivera, J; Del Pino, M; Fernández, E; Fernández, IM; Hernández, D; Luño, J; Paniagua, J; Posada de la Paz, M; Rodríguez-Pérez, JC; Santamaría, R; Torra, R; Torregrosa, JV; Vidau, P | 1 |
| Mignani, R | 1 |
| Barlow, C; Boudes, P; DiMino, T; France, N; Johnson, FK; Mudd, PN; Sitaraman, S; Vosk, J | 1 |
| Germain, DP | 1 |
2 review(s) available for 1-deoxynojirimycin and Kidney Diseases
| Article | Year |
|---|---|
Fabry Nephropathy: An Evidence-Based Narrative Review.
Topics: 1-Deoxynojirimycin; Enzyme Replacement Therapy; Fabry Disease; Female; Galactosidases; Humans; Kidney Diseases; Male; Trihexosylceramides | 2018 |
[Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
Topics: 1-Deoxynojirimycin; Adenoviridae; alpha-Galactosidase; Analgesics; Animals; Antihypertensive Agents; Clinical Trials as Topic; Combined Modality Therapy; Disease Models, Animal; Enzyme Inhibitors; Fabry Disease; Genetic Therapy; Genetic Vectors; Humans; Kidney Diseases; Kidney Transplantation; Mice; Mice, Knockout; Recombinant Fusion Proteins; Renal Dialysis; Retroviridae; X Chromosome | 2002 |
1 trial(s) available for 1-deoxynojirimycin and Kidney Diseases
| Article | Year |
|---|---|
An open-label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function.
Topics: 1-Deoxynojirimycin; Administration, Oral; Adolescent; Adult; Aged; Area Under Curve; Female; Glycoside Hydrolase Inhibitors; Half-Life; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Severity of Illness Index; United States; Young Adult | 2015 |
1 other study(ies) available for 1-deoxynojirimycin and Kidney Diseases
| Article | Year |
|---|---|
[The Fabry nephropathy: new insight in diagnosis, monitoring and treatment].
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Disease Progression; Enzyme Replacement Therapy; Fabry Disease; Female; Glomerulosclerosis, Focal Segmental; Glycolipids; Heterozygote; Humans; Isoenzymes; Kidney Diseases; Male; Oxidative Stress; Podocytes; Recombinant Proteins; Sex Factors; Sphingolipids; Trihexosylceramides | 2019 |